...
首页> 外文期刊>Letters in Drug Design & Discovery >Pretreatment with Huperzine A Protects Acetylcholinesterase in the Rat Brain Against Inhibition by VX and Russian VX
【24h】

Pretreatment with Huperzine A Protects Acetylcholinesterase in the Rat Brain Against Inhibition by VX and Russian VX

机译:石杉碱甲预处理可保护大鼠大脑中的乙酰胆碱酯酶免受VX和俄罗斯VX的抑制

获取原文
获取原文并翻译 | 示例

摘要

Organophosphate nerve agents are still considered as potential threats in both military and terrorism situations. They are potent irreversible inhibitors of acetylcholinesterase in central and also in peripheral compartment. Huperzine A (Hup A) is a reversible AChE inhibitor that crosses the blood-brain barrier. It is presently approved for human use or is in course of clinical trials for the treatment of Alzheimer's disease. This compound has also been successfully tested for pretreatment of organophosphate poisoning. In this study Hup A was tested as a prophylaxis against two V-nerve agents (VX and Russian VX). According to the obtained results, Hup A was able to partially protect AChE in the blood, diaphragm and brain against inhibition caused by Russian VX and VX.
机译:在军事和恐怖主义局势中,有机磷神经毒剂仍被视为潜在威胁。它们是中央和周边区室中有效的不可逆的乙酰胆碱酯酶抑制剂。石杉碱甲(Hup A)是一种可逆的AChE抑制剂,可跨越血脑屏障。目前已批准将其用于人类用途或正在进行临床试验以治疗阿尔茨海默氏病。该化合物也已成功测试了有机磷中毒的预处理。在这项研究中,Hup A被测试为预防两种V型神经毒剂(VX和俄罗斯VX)。根据获得的结果,Hup A能够部分保护血液,隔膜和大脑中的AChE免受俄罗斯VX和VX引起的抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号